The S&P 500 is down 5.4% year-to-date, but you wouldn’t know it from looking at your portfolio if you’ve been loading up on dividend stocks. Johnson & Johnson is up 16%. Consolidated Edison is up 11.69%. And ETFs like SCHD—the $85 billion behemoth tracking the Dow Jones U.S. Dividend 100—are quietly outperforming the broader market while tech burns.
This isn’t just a blip. It’s a full-blown rotation, and it’s happening for all the obvious reasons: a Fed that’s still waffling on rate cuts, a tech sector that’s finally paying for its froth, and a risk-off mood that’s sending investors scrambling for yield like it’s 2009. But here’s the thing—Bank of America just issued a dire warning, and it’s not about dividends. It’s about the way everyone’s piling into them.
The Dividend Mirage
Let’s be clear: Dividend stocks aren’t a bad idea. They’re a classic idea—a way to generate income, smooth out volatility, and own companies with real cash flows instead of pie-in-the-sky growth narratives. But that’s not why most people are buying them right now. They’re buying them because they’re up, and because everyone else is buying them, and because the alternative (tech, small-caps, crypto) is getting crushed.
This is the definition of a crowded trade, and crowded trades have a nasty habit of turning into value traps. Remember 2021, when everyone and their dog was piling into meme stocks? Or 2022, when "recession-proof" consumer staples became the most expensive sector in the market? Dividend stocks aren’t immune to this dynamic. In fact, they might be more vulnerable, because the narrative around them is so seductive: "I’m getting paid to wait."
The most dangerous phrase in investing isn’t ‘This time is different.’ It’s ‘I’m getting paid to wait.’
Bank of America’s Warning: It’s Not About the Dividends
Bank of America’s latest note isn’t a bearish call on dividends themselves. It’s a warning about the complacency that comes with them. The bank’s strategists aren’t saying "sell." They’re saying "stop assuming this is a free lunch." And they’ve got a point.
Here’s the reality: Dividend stocks aren’t inherently safer than growth stocks. They’re just different risks. A high-yield stock like Consolidated Edison might look stable—until it doesn’t. (Ask anyone who owned AT&T in 2022, when it cut its dividend and the stock cratered 45%.) A Dividend Aristocrat like Johnson & Johnson might have 60 years of payout hikes under its belt, but that doesn’t mean it’s immune to valuation bubbles. (JNJ’s forward P/E is still 22x, well above its 10-year average.)
The problem isn’t the dividends. It’s the assumption that dividends = safety. That’s how you end up with a market where everyone’s chasing the same handful of stocks, bidding them up to levels that don’t make sense—all while convincing themselves they’re being "conservative."
The ETFs Everyone’s Buying (And Whether They’re Worth It)
If you’re going to play the dividend game, you’re probably doing it through an ETF. And right now, two funds are dominating the conversation: SCHD and HNDL. But they’re not the same thing—not even close.
SCHD is the benchmark for a reason. It’s cheap (0.06% expense ratio), it’s liquid, and it’s packed with blue-chip names like J&J, Procter & Gamble, and Home Depot. But here’s the catch: It’s not diversified. It’s 100% U.S. equities, and it’s heavily tilted toward sectors that are already getting bid up (healthcare, consumer staples). If you’re buying SCHD, you’re making a bet on those sectors—and little else.
HNDL is the anti-SCHD. It’s not trying to beat the market—it’s trying to replace it, with a yield that’s more than double SCHD’s. But that yield comes with trade-offs. The fund’s 0.90% expense ratio is 15x higher than SCHD’s, and its multi-asset approach means you’re not just betting on dividends—you’re betting on bonds, REITs, and preferreds, too. In a rising-rate environment, that’s a risk.